UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

____ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

(Print or Type Responses)

1. Name and Address of Reporting Person*

        Lucas                             Ronald                                                  
        (Last)                            (First)                                     (Middle)

       3209 S. Pemberton Circle                                                            
        (Street)

        Houston                           TX                                  77025-4329 
        (City)                             (State)                                     (Zip)

2. Issuer Name and Ticker or Trading Symbol Stage Stores, Inc. ("STGS")

3. I.R.S. Identification Number of Reporting Person, if an Entity
     (Voluntary)

4. Statement for Month/Year                                             May 2002

5. If Amendment, Date of Original (Month/Year)

6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
           Director   X    Officer ____10% Owner ___ Other
    (give title below) (specify below)

    Executive Vice President, Human Resources

7. Individual or Joint/Group Filing (Check Applicable Line)

    X     Form filed by One Reporting Person

            Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

 
1. Title of Security
 (Instr. 3)


2. Transaction Date
(month/day/year)


3. Transaction Code
(Instr. 8)

Code                            V

Common Stock, $.01 par value

5/28/2002

P
Common Stock, $.01 par value 5/28/2002 P
Common Stock, $.01 par value 5/28/2002 P
     

Table I - Continued

4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)

Amount - (A) -         Price
                   or
                  (D)

5. Amount of Securities Beneficially Owned at End of Month
(Instr. 3 and 4)

6. Ownership Form:
Direct (D) or
Indirect (I)
(Instr. 4)

7. Nature of Indirect Beneficial Ownership
(Instr. 4)

1,000         A              $34.91

1,000

D

  
1,000         A              $34.91 1,000 D  
1,000         A              $34.90 1,000 D  
  Total: 3000 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly
or indirectly.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
 (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date
(mm/dd/yy)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)

6. Date Exercisable and Expiration Date
(mm/dd/yy)

 

 
           
           
           
           

Table II - Continued

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned at End of Month
(Instr. 4)

10. Ownership Form of Derivative Securities Beneficially Owned at End of Month
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)
         
         
         
         

Reminder: Report on a separate line for each class of securities beneficially owned directly
or indirectly.

Explanation of Responses:

 

/s/ Ronald Lucas                                                                   June 4, 2002
**Signature of Reporting Person                                           Date

 

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.